Ascendiant Capital Markets Predicts SurgePays Q1 Earnings

SurgePays, Inc. (NASDAQ:SURGFree Report) – Equities researchers at Ascendiant Capital Markets dropped their Q1 2026 earnings per share estimates for SurgePays in a report released on Thursday, April 16th. Ascendiant Capital Markets analyst E. Woo now forecasts that the medical equipment provider will post earnings per share of ($0.16) for the quarter, down from their prior estimate of $0.01. Ascendiant Capital Markets has a “Buy” rating and a $5.00 price target on the stock. The consensus estimate for SurgePays’ current full-year earnings is ($0.44) per share. Ascendiant Capital Markets also issued estimates for SurgePays’ Q2 2026 earnings at ($0.15) EPS, Q3 2026 earnings at ($0.10) EPS, Q4 2026 earnings at ($0.03) EPS and FY2026 earnings at ($0.44) EPS.

SURG has been the topic of a number of other reports. Weiss Ratings restated a “sell (e+)” rating on shares of SurgePays in a research note on Monday, December 29th. Zacks Research upgraded shares of SurgePays from a “strong sell” rating to a “hold” rating in a research note on Monday, February 23rd. Finally, Wall Street Zen raised shares of SurgePays to a “sell” rating in a research report on Saturday, January 3rd. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $5.00.

Get Our Latest Stock Analysis on SURG

SurgePays Price Performance

SURG stock opened at $0.67 on Thursday. The business’s 50-day moving average is $0.78 and its two-hundred day moving average is $1.54. The firm has a market capitalization of $16.78 million, a P/E ratio of -0.37 and a beta of 0.54. SurgePays has a 1 year low of $0.46 and a 1 year high of $3.47.

Institutional Investors Weigh In On SurgePays

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Jones Financial Companies Lllp boosted its stake in SurgePays by 34,091.3% in the first quarter. Jones Financial Companies Lllp now owns 51,287 shares of the medical equipment provider’s stock valued at $106,000 after acquiring an additional 51,137 shares in the last quarter. Goldman Sachs Group Inc. purchased a new stake in shares of SurgePays in the 1st quarter valued at about $28,000. Cetera Investment Advisers lifted its holdings in shares of SurgePays by 61.0% in the 2nd quarter. Cetera Investment Advisers now owns 45,400 shares of the medical equipment provider’s stock valued at $141,000 after purchasing an additional 17,200 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of SurgePays in the 2nd quarter valued at about $125,000. Finally, NewEdge Advisors LLC grew its stake in SurgePays by 46.2% during the 2nd quarter. NewEdge Advisors LLC now owns 19,000 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 6,000 shares during the last quarter. 6.94% of the stock is owned by hedge funds and other institutional investors.

SurgePays News Summary

Here are the key news stories impacting SurgePays this week:

  • Positive Sentiment: Ascendiant maintained a “Buy” rating and a $5.00 price target and issued a 2027 outlook that projects a return to profitability (FY2027 EPS ~ $0.06), which supports a longer‑term recovery narrative. Ascendiant 2027 estimates
  • Neutral Sentiment: Ascendiant published detailed 2027 quarterly estimates showing mixed quarters (some small losses early in 2027 and positive quarters later), indicating recovery is expected but uneven — this tempers near‑term confidence while giving a path to earnings improvement. Ascendiant 2027 quarterly outlook
  • Negative Sentiment: Ascendiant sharply cut 2026 guidance: Q1 2026 EPS to ($0.16) from $0.01, Q2 to ($0.15) from $0.01, Q3 to ($0.10) from $0.06, Q4 to ($0.03) from $0.12, and slashed FY2026 to ($0.44) from $0.20 — the magnitude of these downgrades is the primary driver of today’s sell‑off. Ascendiant 2026 cuts

SurgePays Company Profile

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

Read More

Earnings History and Estimates for SurgePays (NASDAQ:SURG)

Receive News & Ratings for SurgePays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurgePays and related companies with MarketBeat.com's FREE daily email newsletter.